P
Phil
Biotech & Life Sciences · San Francisco, United States · Founded 2015
End-to-end prescription management and delivery service connecting patients with local pharmacies MoreLess
Phil.us is a healthcare technology startup that aims to revolutionize the way patients access their medications. The company operates in the healthcare and pharmaceutical markets, serving both healthcare providers (HCPs) and patients. Its primary offering is the PhilRx platform, a digital tool designed to streamline the process of obtaining prescribed medications.
The platform's main features include a national dispense network, real-time HIPAA compliant data, and actionable insights. It simplifies the prior authorization process, ensuring that patients can start their therapy without delay. By negotiating formulary access, Phil.us guarantees that prescriptions are covered by insurance, reducing the financial burden on patients.
The company's business model is centered around improving patient adherence to medication regimens and increasing the number of prescriptions covered by insurance. This is achieved by removing barriers to medication access and providing a seamless experience for both patients and healthcare providers.
Phil.us also offers consulting services to help healthcare providers optimize their channel strategies and build effective telemedicine programs. These services aim to improve patient access and drive transformative brand outcomes.
In terms of revenue generation, Phil.us likely makes money through a combination of platform subscription fees from healthcare providers, consultation fees, and possibly a percentage from each prescription filled through their platform.
In conclusion, Phil.us is a promising startup that leverages technology to simplify medication access and improve patient outcomes in the healthcare sector.
Keywords: Healthcare Technology, Patient Access, Medication Adherence, Prescription Coverage, Prior Authorization, Telemedicine, Consulting Services, HIPAA Compliant Data, Pharmaceutical Market, National Dispense Network.
Company overview
Phil company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2015
- Headquarters
- San Francisco, United States
- Employees
- 284
- Open positions
- 15
- Dealroom signal
- 83.7
Valuation & funding
Phil funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Jul 2025 | $60M | — | K2 HealthVentures | ↗ |
| SERIES DOther financing | Jun 2021 | $56M | $224M | Warburg Pincus | — |
| SERIES BOther financing | May 2019 | $25M | $100M | Uncork Capital · Tarsadia Investments · GreatPoint Ventures · Crosslink Capital | — |
| SERIES BOther financing | Jun 2018 | $0 | — | FJ Labs | — |
| SERIES AOther financing | Aug 2017 | $10M | $40M | Silicon Valley Bank · SV Angel · Uncork Capital · Tom Williams | ↗ |
| EARLY VCOther financing | Nov 2016 | Undisclosed | — | ||
| SEEDOther financing | Aug 2015 | Jose Marin · Forerunner Ventures · Tom Williams · Fabrice Grinda | — |
Growth signals
Phil website traffic
Latest recorded traffic for Phil is 330K monthly website visits, up 3.1% over the last three months. Phil's team declined 1.4% over the past year.
Hiring
Open positions at Phil
Current openings linked to this company in Dealroom.
Comparisons
Phil compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Phil's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Phil has talent and traffic
team presence
In the news
Latest news about Phil
Recent press, funding announcements, and product moves mentioning Phil — open to read from the original sources.
Market sentiment
What the market is saying about Phil
An AI-synthesized read of the highest-engagement posts about Phil on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Phil’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






















